Clinical Aspects of Breast Cancer

Author:

Karrar Hani Raka,Nouh Mahmoud Ismail,Alanazi Badriah Mohammed,Hakami Amro Othman Ahmed,Alzahrani Wejdan Jamaan S,Aldoweirah Waleed Khalid,Alanazi Waleed Salman,Alshammari Nasser Emad,Alanazi Bassam Mohammed,Alharbi Rahaf abed,Alshammari Njood Hamad,Alzahrani Hadeel Saleh,Alghamdi Abdullah Salem A,Alanazi Fahad Wadi

Abstract

Breast cancer is considered one of the major healthcare problems and one of the top biomedical research priorities among all biomedical research. Breast cancer is a common but extremely complex disease. The incidence of breast cancer becoming more aggressive is increasing, with around one million and seven hundred thousand new cases that get worse yearly, and this incidence is expected to increase significantly in the next 5–10 years. These rates are suggestive of the slow progress of this disease. Worldwide, Breast cancer is the most common cancer affecting women. The mortality rates for women who are already diagnosed with breast cancer have improved, but even then, the median survival in the metastatic stage is low, around 24 months. For the treatment, chemotherapy is the gold-standard approach for most cancer types and the modest improvement in both survival rates and toxicity reduction. Every newly diagnosed breast cancer should be presented at a multidisciplinary conference to ensure optimal management by all specialties involved. A careful history of a woman’s risk and symptoms and a thorough physical examination are important in the evaluation of breast problems and appropriately timed imaging and diagnostic studies are also important. Early detection of breast cancer at a stage when it is potentially curable and there is the possibility of saving a breast should be the goal of all health care professionals. Also, careful consideration should be given to the unique nature of each tumor and patient. This article aims to provide a brief introduction and the clinical picture of the disease, Etiology, Pathophysiology, Epidemiology, Nutrition, Prevention, and good practice management advice. Keywords: Breast Cancer, BRCA1 gene, BRCA2 gene, Type one Diabetes mullites. Type Two Diabetes Mellites.

Publisher

Medi + World International

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3